Drug Profile
Piclozotan
Alternative Names: SUN 4057; SUN N 4057Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Asubio Pharma
- Class Anti-ischaemics; Neuroprotectants; Oxazepines; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Dyskinesias
- Discontinued Stroke
Most Recent Events
- 13 May 2014 No development reported - Phase-II for Dyskinesia in USA, Guatemala & Romania (IV)
- 11 Jun 2009 Pharmacodynamics data from a preclinical trial in Parkinson's disease presented at the 13th International Congress of Parkinson's Disease and Movement Disorders (PDMD-2009)
- 15 Jul 2008 Discontinued - Phase-II for Stroke in European Union (IV)